Rogco LP’s Gilead Sciences GILD Stock Holding History

Rogco LP’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40	Closed	-$3K	–	258
2023 Q3	$3K	Buy	+40	New	+$3.08K	﹤0.01%	238

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rogco LP's GILD Position: Q4 2023 in Review

Rogco LP sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 40 shares — an estimated $3K sold.

Rogco LP first reported a position in GILD in Q3 2023 and held it in 1 quarter. The position peaked at $3K in Q3 2023. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Rogco LP reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Rogco LP sold 40 Gilead Sciences shares in Q4 2023, an estimated $3K.
Rogco LP first reported a position in Gilead Sciences in Q3 2023 and held it in 1 quarter.
Rogco LP's Gilead Sciences position peaked at $3K in Q3 2023.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Rogco LP's 13F filing for Q4 2023, filed 6 Feb 2024.